Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
Top Cited Papers
Open Access
- 31 August 2011
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 10 (10), 898-908
- https://doi.org/10.1016/s1474-4422(11)70175-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A map of human genome variation from population-scale sequencingNature, 2010
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's diseaseNature Medicine, 2010
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseMovement Disorders, 2010
- Methods for Detecting Associations with Rare Variants for Common Diseases: Application to Analysis of Sequence DataAmerican Journal of Human Genetics, 2008
- Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPaseProceedings of the National Academy of Sciences, 2008
- A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwanneurogenetics, 2006
- Lrrk2 pathogenic substitutions in Parkinson's diseaseneurogenetics, 2005
- Multiple Testing. Part I. Single-Step Procedures for Control of General Type I Error RatesStatistical Applications in Genetics and Molecular Biology, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986